Larkspur Health Acquisition Corp (LSPRU)

Sector:
FINANCE
Industry:
GENERAL FINANCE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Daniel J. O'Connor
Employees:
2
217 W. MAIN STREET, SOMERVILLE, NJ, 08876
908-370-5102

Larkspur Health Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was incorporated in 2021 and is based in Bridgewater, New Jersey.

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 5.014 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.55
Price to Revenue0.0 Debt to Equity0.0 EBITDA0
Price to Book Value0.2185 Operating Margin0.0 Enterprise Value4.155 Million
Current Ratio0.106 EPS Growth0 Quick Ratio0.022
1 Yr BETA 1.4675 52-week High/Low 21.0 / 9.6 Profit Margin0.0
Operating Cash Flow Growth0.0 Free Cash Flow to Firm (FCFF) TTM 0 Free Cash Flow to Equity (FCFE) TTM
Altman Z-Score-3.9377
View SEC Filings from LSPRU instead.

View recent insider trading info

Larkspur Health Acquisition Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding LSPRU (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LSPRU

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-12-14 by FINIZIO ROBERT G
  • 4: filed on 2022-12-14 by WOLFE PETER
  • 4: filed on 2022-12-14 by LABELLA NICHOLAS A. JR.
  • 4: filed on 2022-12-14 by CASHMERE KAREN A.
  • 3: filed on 2022-12-13 by GLOVER STEPHEN C.
  • 3: filed on 2022-12-13 by FINIZIO ROBERT G
  • 3: filed on 2022-12-13 by WOLFE PETER
  • 3: filed on 2022-12-13 by LABELLA NICHOLAS A. JR.
  • 3: filed on 2022-12-13 by PARK MIN-CHUL
  • 3: filed on 2022-12-13 by CASHMERE KAREN A.

    • Events (8k)

  • 8-K: filed on 2023-11-30:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-17:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-11-02:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K/A: filed on 2023-09-20:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-14:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-08:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-08-18:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
  • 8-K: filed on 2023-07-26:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-12:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-05-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GLOVER STEPHEN C. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 0 2022-12-12 1

    LABELLA NICHOLAS A. JR. CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2022-12-12 2

    FINIZIO ROBERT G

    • Director
    		 0 2022-12-12 2

    WOLFE PETER CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2022-12-12 2

    CASHMERE KAREN A. CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2022-12-12 2

    PARK MIN-CHUL

    • Director
    		 0 2022-12-12 2

    A.G.P. / ALLIANCE GLOBAL PARTNERS CORP.

    • 10% Owner
    		 450,270 2022-02-03 0

    O'CONNOR DANIEL J. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 42,005 2022-01-06 0

    BRIONES DAVID S. CHIEF FINANCIAL OFFICER

    • Officer
    • Director
    		 10,752 2022-01-06 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 22:15:03 UTC -18.2083 22.0283 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 21:45:03 UTC -30.0762 33.8962 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 21:15:03 UTC -30.0762 33.8962 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 20:45:04 UTC -30.0762 33.8962 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 20:15:03 UTC -30.0762 33.8962 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 19:45:04 UTC -30.0762 33.8962 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 19:15:04 UTC -30.0762 33.8962 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 18:45:04 UTC -30.0762 33.8962 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 18:15:04 UTC -30.0762 33.8962 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 17:45:04 UTC -30.0762 33.8962 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 17:15:03 UTC -30.0762 33.8962 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 16:45:03 UTC -29.7768 33.5968 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 16:15:03 UTC -29.7768 33.5968 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 15:45:03 UTC -29.7768 33.5968 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 15:15:03 UTC -29.7768 33.5968 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 14:45:03 UTC -29.7768 33.5968 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 14:15:03 UTC -29.7768 33.5968 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 13:45:03 UTC -14.542 18.362 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 13:15:03 UTC -14.542 18.362 400
    LARKSPUR HEALTH ACQUISITION LSPRU 2022-12-07 12:45:04 UTC -14.542 18.362 400

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments